| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.2 | 0.4 |